Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-032404

President & Immunovant CEO sold 100,000 shares at $11.72 ($1,172,000)

  • President & Immunovant CEO acquired 100,000 shares (option exercise)
  • President & Immunovant CEO gave up 7,051 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2025-08-20 Shares withheld for taxes 10b5-1 −7,051 $11.72 $82,638 1,653,585 D: show line 1 in the form
Venker Eric President & Immunovant CEO 2025-08-20 Option exercise 10b5-1 +100,000 $3.85 $385,000 1,753,585 D: show line 2 in the form
Venker Eric President & Immunovant CEO 2025-08-20 Sale 10b5-1 −100,000 $11.72 $1,172,000 1,653,585 D: show line 3 in the form
Open-market sales · 100,000 sh · avg $11.72 · $1,172,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2025-08-20 Option exercise · Stock Option (Right to Buy) 10b5-1 −100,000 8,038,897 D: show line 4 in the form
Loading xslF345X05/form4.xml…